ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 10, 2010, Pages 698-705

  Junyent, M ^a   Parnell, L D ^a   Lai, C Q ^a   Arnett, D K ^b   Tsai, M Y ^c   Kabagambe, E K ^b   Straka, R J ^d   Province, M ^e   An, P ^e   Smith, C E ^a   Lee, Y C ^a   Borecki, I ^e   Ordovas J M ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMI; Gene diet interaction; HDL cholesterol; Insulin concentrations; Obesity

Indexed keywords

ADAM PROTEIN; EDIBLE OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ADIPOCYTE; ADULT; AGED; ALLELE; ARTICLE; BLOOD; BODY MASS; DIET; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADAM PROTEINS; ADIPOCYTES; ADULT; AGED; ALLELES; BODY MASS INDEX; CHOLESTEROL, HDL; DIET; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78649754353     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.06.011     Document Type: Article

References (31)

1. Sullivan P.W., Ghushchyan V.H., Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 2008, 17:1063-1071.
2. Clément K. Genetics of human obesity. Proc Nutr Soc 2005, 64:133-142.
3. Ordovas J.M., Shen J. Gene-environment interactions and susceptibility to metabolic syndrome and other chronic diseases. J Periodontol 2008, 79:1508-1513.
4. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775.
5. Dixon A.L., Liang L., Moffatt M.F., Chen W., Heath S., Wong K.C. A genome-wide association study of global gene expression. Nat Genet 2007, 39:1202-1207.
6. Edwards D.R., Handsley M.M., Pennington C.J. The ADAM metalloproteinases. Mol Aspects Med 2008, 29:258-289.
7. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
8. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
9. Voros G., Maquoi E., Collen D., Lijnen H.R. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-α, TNF-α converting enzyme and ADAMS family members in murine fat territories. Biochim Biophys Acta 2003, 1625:36-42.
10. Wang Y., Kim K.A., Kim J.H., Sul H.S. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J Nutr 2006, 136:2953-2956.
11. Morange P.E., Tregouet D.A., Godefroy T., Saut N., Bickel C., Rupprecht H.K., et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med 2008, 86:1153-1161.
12. Zhao L.J., Xiong D.H., Pan F., Liu X.-G., Recker R.R., Deng H.W. Polymorphisms of the tumor necrosis factor-alpha receptor 2 gene are associated with obesity phenotypes among 405 Caucasian nuclear families. Hum Genet 2008, 124:171-177.
13. Brand E., Schorr U., Kunz I., Kertmen E., Ringel J., Distler A., et al. Tumor necrosis factor-alpha - -308G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 2001, 25:581-585.
14. Corbalán M.S., Marti A., Forga L., Patiño A., Martínez-Gonzalez M.A., Martínez J.A. Influence of two polymorphisms of the tumoral necrosis factor-alpha gene on the obesity phenotype. Diabetes Nutr Metab 2004, 17:17-22.
15. Sookoian S.C., Gonzalez C., Pirola C.J. Meta-analysis on the G-308A tumor necrosis factor α gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005, 13:2122-2131.
16. Walston J., Seibert M., Yen C.-J., Cheskin L.J., Andersen R.E. Tumor necrosis factor-α-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance. Diabetes 1999, 48:2096-2098.
17. Rasmussen S.K., Urhammer S.A., Jensen J.N., Hansen T., Borch-Johnsen K., Pedersen O. The -238 and -308 G > A polymorphisms of the tumor necrosis factor α gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 2000, 85:1731-1734.
18. Higgins M., Province M., Heiss G., Eckfeldt J., Ellison R.C., Folsom A.R., et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996, 143:1219-1228.
19. Junyent M., Lee Y., Smith C.E., Arnett D.K., Tsai M.Y., Kabagambe E.K., et al. The effect of a novel intergenic polymorphism (rs11774572) on HDL cholesterol concentrations depends on TaqIB polymorphism in the cholesterol ester transfer protein gene. Nutr Metab Cardiovasc Dis 2009, [Epub ahead of print].
20. Thompson F.E., Subar A.F., Brown C.C., Smith A.F., Sharbaugh C.O., Jobe J.B., et al. Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J Am Diet Assoc 2002, 102:212-225.
21. Subar A.F., Thompson F.E., Kipnis V., Midthune D., Hurwitz P., McNutt S., et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001, 154:1089-1099.
22. Marinescu V.D., Kohane I.S., Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005, 6:79.
23. Tellier E., Canault M., Poggi M., Bonardo B., Nicolay A., Alessi M., et al. HDLs activate ADAM17-dependent shedding. J Cell Physiol 2008, 214:687-693.
24. Stride A., Ellard S., Clark P., Shakespeare L., Salzmann M., Shepherd M., et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 2005, 28:1751-1756.
25. Wolfrum C., Shih D.Q., Kuwajima S., Norris A.W., Kahn C.R., Stoffel M. Role of FOXA2 in adipocyte metabolism and differentiation. J Clin Invest 2003, 112:345-356.
26. Sampath H., Ntambi J.M. Polyunsaturated fatty acid regulation of gene expression. Annu Rev Nutr 2005, 25:317-340.
27. Ramel A., Martinez A., Kiely M., Morais G., Bandarra N.M., Throsdottir I. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008, 51:1261-1268.
28. Madsen L., Pedersen L.M., Liaset B., Ma T., Petersen R.K., van den Berg S., et al. cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem 2008, 283:7196-7205.
29. Fontaine-Bisson B., El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J Nutrigenet Nutrigenomics 2008, 1:215-223.
30. Nieters A., Becker N., Linseisen J. Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort. Eur J Nutr 2002, 41:210-221.
31. Madsen L., Petersen R.K., Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim Biophys Acta 2005, 1740:266-286.